James Andrew Case

James Andrew (Andy) Case is a Supply Chain Management and Supply Chain Technology professional in the Bio-Pharmaceutical space. He is a subject matter expert in Chain of Identity and Chain of Custody for individualized cell therapies and the orchestration platforms designed to control COI/COC and End-to-End Value chain activities for these therapies. Andy worked for four years at Novartis as Sr. Director of Supply Chain Technology and as a member of the team that launched Kymriah where he was also the System Owner for CellChain the orchestration platform established by Novartis for its Cell and Gene therapies business.

Andy joined Genentech in May 2020 as Head of Supply Chain, Cell and Gene Therapies (PTC-CGTi SC) where he is establishing supply chain capabilities for an emerging portfolio of individualized cell therapies and gene therapies.

Andy has a BS in Civil Engineering from Texas A&M University and a MBA from IMD in Lausanne, Switzerland.